View Rule

This rule finalizes the interim final rule that revises requirements related to beneficiary access to covered Part D drugs. Under these requirements, pharmacy claims and beneficiary requests for reimbursement for Medicare Part D prescriptions, written by prescribers other than physicians and eligible professionals who are permitted by State or other applicable law to prescribe medications, will not be rejected at the point of sale or denied by the plan if all other requirements are met.  In addition, a plan sponsor will not reject a claim or beneficiary request for reimbursement for a drug without first providing provisional coverage of the drug and individualized written notice to the beneficiary.  This rule also revises certain terminology to assure consistency with existing policy and to improve clarity.

Overall Description of Deadline: MMA section 902 requires Medicare final rules publish within three-years of a proposed or interim final rule. Rule may publish before the three-year deadline.